Traws Pharma, Inc. — Director's Dealing 2013

Aug 1, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Onconova Therapeutics, Inc. (ONTX)
CIK: 0001130598
Period of Report: 2013-07-30

Reporting Person: MCKEARN THOMAS J (President, R&D)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-07-30	Common Stock	P	3333	$15	Acquired	3333	Direct